To Treat Disease, Doctors Can Now Edit Genes Inside the Body

WSJ Tech News Briefing

The Wall Street Journal

News, Tech News

4.6 • 1.6K Ratings

🗓️ 15 March 2024

⏱️ 12 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Many conditions, such as sickle cell and heart disease, are caused by genetic mutations. Over the past few years, scientists have learned how to treat some of those conditions by introducing cells that have been edited with bioengineering tools like CRISPR. But in the future, doctors could treat those conditions by editing patients’ cells while they’re still in their bodies—an approach called in vivo gene editing. Cordilia James spoke with WSJ senior writer Betsy McKay about how the approach works and its potential risks. Alex Ossola hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	The less your business spends the more margin you keep.
0:03.5	Net Suite by Oracle brings accounting, finance, inventory, and HR into one proven platform,
0:09.5	helping you reduce costs everywhere.
0:12.0	Now through April 15th, NetSuite is offering a one-of-a-kind flexible financing program.
0:17.9	So head to NetSuite.com slash Wall Street right now. Welcome to Tech News Briefing.
0:27.0	It's Friday, March 15th.
0:29.0	I'm Alex Oscela for the Wall Street Journal.
0:31.8	Coming up on today's show, thanks to the artificial intelligence boom, chipmaker
0:35.9	Invidia's profits are sky high.
0:38.7	But the company has also become one of the business world's hottest venture capital
0:42.3	investors. We'll find out's hottest venture capital investors.
0:43.2	We'll find out what Invidia's investment strategy means for the future of AI,
0:47.2	from W.S.J.
0:48.4	Semiconductor's reporter Aesophitch.
0:50.3	And then, to treat complex medical conditions, doctors have a new approach, tweaking disease-causing mutations directly in patient cells.
0:59.0	W.S.J. Senior writer Betsy McKay breaks down how it works and how it might go wrong.
1:05.0	But first,
1:09.0	Invidia has become an investor darling as its AI chip business has boomed.
1:14.2	More quietly, the company has been doing some investing itself.
1:17.9	Last year, NVIDIA invested in about three dozen startups, more than tripling its activity from the year before.
1:24.0	W.S.J. S. Semiconductor's reporter Aisa Fitch
1:26.6	is here to tell us more about the company's strategy.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.